GlobeNewswire 11.12.2025 Oruka Therapeutics Announces New Board Member and Board Transition
GlobeNewswire 10.12.2025 Halper Sadeh LLC Encourages CADE, MRSN, CDTX Shareholders to Contact the Firm to Discuss Their Right...
GlobeNewswire 10.12.2025 MAIA Takes Aim at a $50B Immunotherapy Market with Breakthrough Telomere-Targeting Approach
GlobeNewswire 10.12.2025 BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Mersana The...
GlobeNewswire 10.12.2025 Medicenna Updates MDNA11 Clinical Trial Results at the ESMO-IO Congress 2025, Further Bolstering its...
GlobeNewswire 09.12.2025 Formycon and Zydus partner for exclusive licensing and supply agreement of FYB206, a biosimilar to K...
GlobeNewswire 09.12.2025 Ligand Hosts 2025 Investor Day and Introduces 2026 Guidance
GlobeNewswire 09.12.2025 ASH 2025 | Updated Data for Ascentage Pharma‘s Olverembatinib in Second-Line CML-CP Showing Encourag...
GlobeNewswire 09.12.2025 ASH 2025 | Ascentage Pharma Presents Four-Year Follow-Up Data from Registrational Phase II Study of ...
GlobeNewswire 09.12.2025 ASH 2025 | Ascentage Pharma Presents First Dataset from Phase III POLARIS-1 Study of Olverembatinib ...
GlobeNewswire 08.12.2025 Halper Sadeh LLC Encourages MRSN, CDTX, RYI Shareholders to Contact the Firm to Discuss Their Rights
GlobeNewswire 08.12.2025 Immutep and Dr. Reddy’s enters into Strategic Collaboration for Commercialisation of an Innovative O...
GlobeNewswire 08.12.2025 ASH 2025 | Ascentage Pharma Presents Encouraging Data from Phase Ib/II Study of Bcl-2 Inhibitor Lisa...
GlobeNewswire 06.12.2025 Ascentage Pharma Presents Pivotal China Registrational Study Data for Lisaftoclax in Oral Report at ...
Newsfile Corp 05.12.2025 TempraMed Expands European Footprint with Distribution Partnership in Netherlands, Belgium, and Luxe...
GlobeNewswire 05.12.2025 Ascentage Pharma Announces Global Registrational Phase III Study of Olverembatinib in First-Line Tre...
GlobeNewswire 03.12.2025 The Efficiency Gap: Five Assets Where Price Has Yet To Reflect Reality
GlobeNewswire 02.12.2025 Health-ISAC® Announces results of 2026 Board of Directors Election
GlobeNewswire 02.12.2025 Chronic Rare Diseases in an Aging America: Why HyBryte and Federal Policy Matter Now
GlobeNewswire 02.12.2025 Immutep to Present New Data from AIPAC-003 Phase II at the 2025 San Antonio Breast Cancer Symposium
GlobeNewswire 02.12.2025 Ventyx Provides Clinical and Corporate Updates
TeleTrader 01.12.2025 US closes lower, Dow drops 420 pts
GlobeNewswire 01.12.2025 AIM ImmunoTech to Participate in Live ‘Fireside’ Chat on Virtual Investor Closing Bell Series
GlobeNewswire 01.12.2025 Ascentage Pharma to Host Webcast Highlighting Key Data from ASH 2025
GlobeNewswire 01.12.2025 Salarius Pharmaceuticals to Collaborate with Texas Biomedical Research Institute on Avian Flu Study